Concerted efforts are driving positive change in the pediatric and rare liver disease community! Read on for details: Insight on Unmet Needs in Primary Biliary Cholangitis In this Peer Exchange...
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as...
Read along for some updates about cutting-edge technology in rare liver disease that should improve prompt diagnosis, ongoing feedback, and effective interventions. Vote for GLI for a Healio...
In July, GLI used its voice to challenge policymakers to take steps to advance high quality, equitable care for everyone. We met with key Members of Congress to push for action to reform the organ...
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world. Vote for GLI for a Healio Disruptive Innovators Award Great news! Healio named GLI...
GLI and Others Nominate Julius M. Wilder MD, PhD to National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC) Global Liver Institute is pleased to nominate Julius M....
GLI Urges Passage of the Treat and Reduce Obesity Act (TROA) Global Liver Institute recognizes the relationship between nonalcoholic fatty liver disease (NAFLD), its advanced form,...
International NASH Day was a success! The 6th International NASH Day was a resounding global success, with over 100 partners from 55 countries participating. Our hashtag #NASHDay reached over 10...
Actively supporting advocacy efforts and engaging in novel clinical trials can provide patients with a sense of hope for potential therapies and assurance in the management of their condition. Read...
It’s not only important to GLI to keep you updated; we value your input and updates. This is a reminder to Liver Cancers Council members and supporters to share news to be featured in our monthly...
Recent News
NASH News - Tackling Fatty Liver Disease As the field of NASH is on the verge of clinical and diagnostic breakthroughs, discover how Global Liver Institute (GLI) is promoting healthier living through our personalized nutrition solution, as well as how we are...
During the Congressional recess in August, GLI prepared for a busy fall. Congress returns in September to advance appropriations bills and debate key legislative priorities. The Administration will continue its work related to Medicare coverage policy, FDA...
At GLI, we aim to keep you updated on the latest innovations and advancements in liver cancer. As we begin to approach Liver Cancer Awareness Month, take a look at our liver cancer resources that are available on our Liver Central website. #OctoberIs4Livers Liver...
Concerted efforts are driving positive change in the pediatric and rare liver disease community! Read on for details: Insight on Unmet Needs in Primary Biliary Cholangitis In this Peer Exchange discussion on HCP Live, liver disease experts discussed the unmet needs...
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as director of the National Institute of Allergy and Infectious Diseases...
